lapatinib has been researched along with acridines in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (acridines) | Trials (acridines) | Recent Studies (post-2010) (acridines) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 6,987 | 169 | 856 |
| Protein | Taxonomy | lapatinib (IC50) | acridines (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Homo sapiens (human) | 6.84 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grabowski, T; Grześkowiak, E; Karbownik, A; Klupczynska, A; Plewa, S; Płotek, W; Sobańska, K; Szałek, E | 1 |
1 other study(ies) available for lapatinib and acridines
| Article | Year |
|---|---|
The influence of the coadministration of the p-glycoprotein modulator elacridar on the pharmacokinetics of lapatinib and its distribution in the brain and cerebrospinal fluid.
Topics: Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Blood-Brain Barrier; Brain; Cerebrospinal Fluid; Lapatinib; Male; Protein Transport; Rats; Rats, Wistar; Tetrahydroisoquinolines | 2020 |